William P Sheridan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William P Sheridan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William P Sheridan. William P Sheridan is Senior VP - CMO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and SR VP - CMO in BIOCRYST PHARMACEUTICALS INC ($BCRX).
Latest Insider Trading Transactions of William P Sheridan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2021 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 4.15 | 41,250 | 171,188 | 0 | |
| Feb 24 2021 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 11.57 | 41,250 | 477,263 | 11,475 | 52.7 K to 11.5 K (-78.24 %) |
| Feb 24 2021 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 4.15 | 41,250 | 171,188 | 52,725 | 11.5 K to 52.7 K (+359.48 %) |
| Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 8.31 | 335,000 | 2,783,850 | 335,000 | |
| Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Feb 25 2020 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 11.13 | 22,600 | 251,538 | 22,600 | |
| Dec 19 2019 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 3.23 | 176,000 | 568,480 | 176,000 | |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 7.06 | 335,000 | 2,365,100 | 335,000 | |
| Dec 20 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 7.58 | 20,488 | 155,299 | 2,725 | 23.2 K to 2.7 K (-88.26 %) |
| Aug 13 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 1.42 | 62,500 | 88,750 | 0 | |
| Aug 13 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 7.03 | 62,500 | 439,375 | 23,213 | 85.7 K to 23.2 K (-72.92 %) |
| Aug 13 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 1.42 | 62,500 | 88,750 | 85,713 | 23.2 K to 85.7 K (+269.25 %) |
| Jun 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 2.58 | 42,112 | 108,649 | 0 | |
| Jun 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 6.30 | 42,112 | 265,306 | 21,058 | 63.2 K to 21.1 K (-66.66 %) |
| Jun 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 2.58 | 42,112 | 108,649 | 63,170 | 21.1 K to 63.2 K (+199.98 %) |
| Jan 23 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 5.59 | 4,628 | 25,871 | 18,058 | 22.7 K to 18.1 K (-20.40 %) |
| Jan 03 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 4.91 | 1,169 | 5,740 | 22,686 | 23.9 K to 22.7 K (-4.90 %) |
| Dec 22 2017 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.04 | 100,000 | 504,000 | 100,000 | |
| Nov 15 2017 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 4.72 | 64,310 | 303,543 | 23,855 | 88.2 K to 23.9 K (-72.94 %) |
| Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 11.13 | 33,900 | 377,307 | 33,900 | |
| Mar 01 2017 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.51 | 175,000 | 964,250 | 175,000 | |
| Jan 24 2017 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 5.95 | 5,761 | 34,278 | 82,916 | 88.7 K to 82.9 K (-6.50 %) |
| Jan 03 2017 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 6.33 | 2,081 | 13,173 | 88,677 | 90.8 K to 88.7 K (-2.29 %) |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 3.22 | 148,302 | 477,532 | 148,302 | |
| Mar 03 2016 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 2.13 | 799 | 1,702 | 90,052 | 90.9 K to 90.1 K (-0.88 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 7.55 | 5,359 | 40,460 | 88,967 | 94.3 K to 89 K (-5.68 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 10.32 | 2,081 | 21,476 | 94,326 | 96.4 K to 94.3 K (-2.16 %) |
| Dec 31 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 10.82 | 71,698 | 775,772 | 71,698 | |
| Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 2.58 | 70,389 | 181,604 | 42,112 | |
| Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 15.05 | 70,389 | 1,059,354 | 95,123 | 165.5 K to 95.1 K (-42.53 %) |
| Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 1.20 | 70,389 | 84,467 | 165,512 | 95.1 K to 165.5 K (+74.00 %) |
| Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Mar 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 10.20 | 1,739 | 17,738 | 95,123 | 96.9 K to 95.1 K (-1.80 %) |
| Mar 03 2011 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 4.15 | 55,000 | 228,250 | 55,000 | |
| Mar 03 2011 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 0.00 | 10,000 | 0 | 15,786 | 5.8 K to 15.8 K (+172.83 %) |
| Apr 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | M | 1.20 | 6,093 | 7,312 | 16,407 | |
| Apr 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | M | 2.58 | 12,500 | 32,250 | 112,501 | |
| Apr 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 8.01 | 18,593 | 148,856 | 1,664 | 20.3 K to 1.7 K (-91.79 %) |
| Apr 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | M | 1.20 | 6,093 | 7,312 | 20,257 | 14.2 K to 20.3 K (+43.02 %) |
| Apr 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | M | 2.58 | 12,500 | 32,250 | 14,164 | 1.7 K to 14.2 K (+751.20 %) |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 6.68 | 64,000 | 427,520 | 64,000 | |
| Jan 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | M | 2.58 | 4,166 | 10,748 | 125,001 | |
| Jan 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 8.05 | 4,166 | 33,536 | 0 | 4.2 K to 0 (-100.00 %) |
| Jan 12 2010 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | M | 2.58 | 4,166 | 10,748 | 4,166 | 0 to 4.2 K |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | M | 2.58 | 4,167 | 10,751 | 129,167 | |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 8.17 | 4,167 | 34,044 | 0 | 4.2 K to 0 (-100.00 %) |
| Dec 02 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | M | 2.58 | 4,167 | 10,751 | 4,167 | 0 to 4.2 K |
| Nov 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | S | 2.58 | 4,167 | 10,751 | 133,334 | |
| Oct 15 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | S | 2.58 | 62,499 | 161,247 | 137,501 | |
| Oct 15 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 8.92 | 6,000 | 53,540 | 0 | 6 K to 0 (-100.00 %) |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 1.20 | 22,500 | 27,000 | 22,500 | |
| Feb 03 2009 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | P | 1.62 | 3,000 | 4,845 | 3,000 | 0 to 3 K |
| Jul 03 2008 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 2.58 | 200,000 | 516,000 | 200,000 |
Page: 1